Radiation Oncology: Page 45

Accuray revenue climbs in Q3
By AuntMinnie.com staff writers
Radiation therapy firm Accuray posted a 5% increase in revenue in its fiscal third quarter, but costs associated with its pending acquisition of TomoTherapy pushed the firm into the red.
May 5, 2011
ASTRO issues thoracic radiotherapy guidelines
By AuntMinnie.com staff writers
The American Society for Radiation Oncology (ASTRO) has issued evidence-based guidelines for the use of external-beam radiation therapy, endobronchial brachytherapy, and concurrent chemotherapy to provide palliative care and treat thoracic symptoms caused by advanced lung cancer.
May 3, 2011
Tissue spacers reduce radiation burn risk to IMRT patients
By Cynthia E. Keen
An injectable tissue spacer can reduce rectal dose and the risk of radiation burns to the rectum of patients undergoing intensity-modulated radiation therapy (IMRT) for prostate cancer, according to a study presented at the Cancer Imaging and Radiation Therapy Symposium held April 29 and 30 in Atlanta.
May 2, 2011
JNCI: IMRT doubles costs for breast cancer patients
By Wayne Forrest
The adoption of intensity-modulated radiation therapy (IMRT) has prompted sharply higher costs for radiation therapy, according to an April 29 article in the Journal of the National Cancer Institute. The study found that it cost twice as much to use IMRT to treat women with breast cancer compared with traditional radiation therapy.
April 27, 2011
Sensus scores Premier deal
By AuntMinnie.com staff writers
Superficial radiation therapy provider Sensus Healthcare has received a contract from group purchasing organization Premier Purchasing Partners.
April 26, 2011
Accuray advances toward TomoTherapy buy
By AuntMinnie.com staff writers
Radiation therapy firm Accuray has passed another hurdle in its proposed $277 million acquisition of TomoTherapy.
April 25, 2011
Varian nets China TrueBeam OK
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems has received clearance to market its TrueBeam system for image-guided radiation therapy in China.
April 25, 2011
Radiotherapy-induced cancer risk is low, study shows
By Cynthia E. Keen
The risk of developing a second cancer from radiation therapy is very low, according to a study of nearly 650,000 cancer survivors published online March 31 in the Lancet Oncology. For every 1,000 patients who receive radiation therapy, only three will develop a cancer within 10 years as a result of the treatment.
March 31, 2011
Radiation therapy wait times meet guidelines in Canada
By Rosemary Frei
A report released this week indicates that 98% of Canadians begin radiation therapy for cancer within four weeks after the patients are ready to receive the treatment, meeting nationally accepted standards. Meanwhile, wait times for imaging procedures varied greatly by province, although the report did not produce a national average.
March 22, 2011
Chemo lowers cancer risk for pediatric Hodgkin's survivors
By Cynthia E. Keen
Childhood cancer survivors who received radiation therapy for Hodgkin's lymphoma had a significantly higher risk of developing a second malignant tumor compared to patients who only received chemotherapy, according to an Australian study published online March 10 in the Annals of Oncology.
March 22, 2011
Varian receives 1st GammaMed order in China
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems has signed its first customer in China for its GammaMed brachytherapy afterloader.
March 15, 2011
Study suggests breast shrinkage not caused by rad therapy
By Cynthia E. Keen
Breast shrinkage can be a devastating toxicity for large-breasted women who undergo breast conservation surgery and radiation therapy. However, surgery rather than radiation therapy appears to be the cause, according to a study published online February 23 in the International Journal of Radiation Oncology, Biology, Physics.
March 14, 2011
Previous Page
Page 45 of 81
Next Page